← SynDRA
VU0364739
SynDRA canonical compound SYN0045534 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PLD2 |
|---|
| Mechanism of action | phospholipase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PLD2 INHIBITOR
- phospholipase inhibitor
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- CHEMBL1254577
- VU 0364739
- VU-0364739
- RefChem:194668
- VU0364739-1
- MLS003509091
- GTPL5287
- orb2278825
- orb3032886
- SCHEMBL14833140
- SCHEMBL29430168
- BDBM87120
- cid_46939577
- HMS3743I07
- EX-A8423
- EBC-419044
- NCGC00370779-02
- DA-78933
- SMR002157265
- HY-150412
- CS-0533377
- T78161
- VU0364739 (3)
- VU 0364739 hydrochloride
- GLXC-02715
- VU0364739-2
- ML271
- EX-A8423A
- VU 0364739 (hydrochloride)
- SMR002531850
- T23512
- orb1703933
- CS-0029322
- VU0364739 hydrochloride
- VU0364739 HCl
- AS-85449
- HY-108616
- H37486
- MLS003875035
Look up VU0364739 in the interactive SynDRA portal →